Israel Englander Io Biotech, Inc. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.88 - $2.98 $1,197 - $1,898
-637 Reduced 3.1%
19,917 $37,000
Q4 2022

Feb 14, 2023
SELL
$2.22 - $3.1 $39,444 - $55,080
-17,768 Reduced 46.37%
20,554 $47,000
Q3 2022

Nov 14, 2022
SELL
$2.51 - $4.85 $19,851 - $38,358
-7,909 Reduced 17.11%
38,322 $104,000

Others Institutions Holding IOBT

# of Institutions
19
Shares Held
23.6M
Call Options Held
0
Put Options Held
0
View Full List

About IO Biotech, Inc.

IOBT Quotes by TradingView
  • Ticker IOBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,815,300
  • Market Cap $23.6M
  • Description
  • IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...
More about IOBT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email